CI
Cigna Corp
NYSE: CI · HEALTHCARE · HEALTHCARE PLANS
$298.00
+1.07% today
Updated 2026-06-12
Market cap
$72.14B
P/E ratio
2.40
P/S ratio
0.26x
EPS (TTM)
$113.72
Dividend yield
2.22%
52W range
$237 – $333
Volume
1.6M
WallStSmart proprietary scores
68
out of 100
Grade: B
Buy
Investment rating
6.7
Growth
B5.5
Quality
C+5.5
Profitability
C+9.3
Valuation
A+5/9
Piotroski F-Score
Moderate
2.5
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$350.36
+17.57%
12-Month target
$265.57
-10.88%
Intrinsic (DCF)
$680.85
Margin of safety
+57.48%
5 Strong Buy15 Buy4 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $864.00M — positive
+ 57.48% below intrinsic value
Risks
- Thin margins at 2.26%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $180.52B | $195.26B | $247.12B | $274.95B | $277.89B | $291.1B |
| Net income | $6.70B | $5.16B | $3.43B | $5.96B | $1.65B | — |
| EPS | — | — | — | — | $113.72 | $31.24 |
| Free cash flow | $7.36B | $10.24B | $8.96B | $8.39B | $864.00M | — |
| Profit margin | 3.71% | 2.64% | 1.39% | 2.17% | 2.26% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-01 | KOKA, DURGA PRASAD | Sale | 729 | $275.53 |
| 2026-05-29 | KURIAN, GEORGE | Buy | 108 | $277.40 |
| 2026-05-13 | CORDANI, DAVID | Sale | 15,458 | — |
Peer comparison
Smart narrative
Cigna Corp trades at $298.00. representing a P/E of 2.40x trailing earnings. Our Smart Value Score of 68/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 2.50, it sits in the grey zone. TTM revenue stands at $277.89B. with profit margins at 2.26%. Our DCF model estimates intrinsic value at $680.85.
Frequently asked questions
What is Cigna Corp's stock price?
Cigna Corp (CI) trades at $298.00, on a P/E of 2.4x and a P/S of 0.3x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Cigna Corp overvalued?
Cigna Corp carries a Smart Value Score of 68/100 (Grade B), which we rate Buy. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $680.85 versus the $298.00 price, a 57.5% margin of safety on a cash flow basis.
What is the price target of Cigna Corp (CI)?
The 12-month analyst consensus target is $350.36, about 17.6% above the current $298.00. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of CI by 2030?
Our research-backed model puts the 2030 base case at $16,872.23, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is the intrinsic value of Cigna Corp (CI)?
Our DCF model estimates intrinsic value at $680.85, a +57.5% margin of safety versus today's $298.00. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Cigna Corp's revenue?
Cigna Corp's trailing twelve-month revenue is $277.89B, and our model projects it reaching about $363.90B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Cigna Corp's Altman Z-Score is 2.50, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryHEALTHCARE PLANS
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.26x
ROE14.90%
Beta0.31
50D MA$278.89
200D MA$282.14
Shares out0.26B
Float0.26B
Short ratio—
Avg volume1.6M
Performance
1 week+0.00%
1 month+2.04%
3 months+8.47%
YTD+5.18%
1 year—
3 years—
5 years—